PERSPECTA

News from every angle

← Back to headlines

AEON Biopharma Regains NYSE American Listing Compliance

AEON Biopharma has regained compliance with NYSE American listing requirements following a $13.6 million offering.

3 Aug, 21:06 — 3 Aug, 21:06
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed9d ago

AEON Biopharma regains NYSE American listing compliance after $13.6M offering

Read full article →

Related Stories

Goldman Sachs Acquires Neos in $2.25 Billion Deal, Expanding ETF Presence

53m ago

Turkish Central Bank Raises 2026 Inflation Forecast

59m ago

Maersk Stock Surges After Unexpected Financial Report

1h ago

Romania Reduces Diesel Excise Tax Amid Rising Prices

1h ago